Therapeutic agent for dyskinesia

Details for Australian Patent Application No. 2006234627 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Hanada, Takahisa; Kuno, Sadako; Mizuta, Eiji; Ueno, Masataka

Agent FB Rice

Pub. Number AU-B-2006234627

PCT Pub. Number WO2006/109876

Priority 2005-112137 08.04.05 JP

Filing date 10 April 2006

Wipo publication date 19 October 2006

Acceptance publication date 11 June 2009

International Classifications

A61K 31/444 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 November 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Therapeutic agent for dyskinesia

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/109876 Priority application(s): WO2006/109876

11 June 2009 Application Accepted

  Published as AU-B-2006234627

6 August 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Jul 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

26 November 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Jul 2009

3 December 2009 Standard Patent Sealed

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006234632-Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders

2006234618-Pyrazolo(1,5-a)pyridine derivative or medically acceptable salt thereof